ARTICLE | Clinical News
Yervoy ipilimumab: Interim Phase II data
June 6, 2016 7:00 AM UTC
Ono Pharmaceutical Co. Ltd. (Tokyo:4528), Osaka, Japan Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Product: Yervoy ipilimumab ( BMS-734016) Business: Cancer Molecular target: Cytotoxic T-ly...